Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Monte Rosa Therapeutics, Inc. | Chief Operating Officer | Common Stock | 30K | $282K | $9.41 | Jan 2, 2025 | Direct |
Monte Rosa Therapeutics, Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 135K | Jan 2, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GLUE | Monte Rosa Therapeutics, Inc. | Jan 2, 2025 | 2 | $0 | 4 | Jan 6, 2025 | Chief Operating Officer |
GLUE | Monte Rosa Therapeutics, Inc. | Jun 3, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Chief Operating Officer |
GLUE | Monte Rosa Therapeutics, Inc. | May 28, 2024 | 0 | $0 | 3 | Jun 5, 2024 | Chief Operating Officer |